Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >= 75 years of age treated with implantable cardioverter defibrillators | Zendy

Cengiz Ermiş | Zendy; Andrew X. Zhu | Zendy; Laura VanHeel | Zendy; R Sakaguchi | Zendy; Keith G. Lurie | Zendy; Fei Lü | Zendy; David G. Benditt | Zendy

Open Access

Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >= 75 years of age treated with implantable cardioverter defibrillators

Author(s) -

Cengiz Ermiş,

Andrew X. Zhu,

Laura VanHeel,

R Sakaguchi,

Keith G. Lurie,

Fei Lü,

David G. Benditt

Publication year - 2007

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eum015

Subject(s) - medicine , ejection fraction , amiodarone , ventricular tachycardia , implantable cardioverter defibrillator , ventricular fibrillation , cardiology , atrial fibrillation , heart failure

Implantable cardioverter defibrillators (ICD) reduce arrhythmic mortality in a wide range of patients with poor left ventricular (LV) function. However, whether ICD therapy is equally effective in younger and older patients remains uncertain. To address this question, we compared ICD-documented ventricular tachyarrhythmia burden in patients < 75 years of age (Group 1) and >or= 75 years of age (Group 2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research